Ashley Milton
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
- Co-authors
- Karthik Venkatakrishnan (7 shared papers)J.-L. Baulieu (1 shared paper)Lydiane Pichard‐Garcia (1 shared paper)Xiaofei Zhou (4 shared papers)P Maurel (1 shared paper)Jean‐Michel Fabre (1 shared paper)Ruth Hyland (1 shared paper)Mark Gardner (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (5 papers)Journal of Clinical Oncology (3 papers)Gastroenterology (3 papers)The Journal of Clinical Pharmacology (3 papers)European Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Ashley Milton
22 papers receiving 310 citations
Peers
Comparison fields: 5 of 71
- Pharmacology 44
- Pharmaceutical Science 32
- Biomaterials 42
- Oncology 73
- Gastroenterology 12
Countries citing papers authored by Ashley Milton
This map shows the geographic impact of Ashley Milton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Milton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Milton more than expected).
Fields of papers citing papers by Ashley Milton
This network shows the impact of papers produced by Ashley Milton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Milton. The network helps show where Ashley Milton may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashley Milton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 39 | |
| 2 | 2001 | 38 | |
| 3 | 2013 | 27 | |
| 4 | 2014 | 25 | |
| 5 | 2013 | 24 | |
| 6 | 2016 | 23 | |
| 7 | 2006 | 21 | |
| 8 | 2006 | 17 | |
| 9 | 2017 | 15 | |
| 10 | 2017 | 14 | |
| 11 | 2017 | 14 | |
| 12 | 2021 | 12 | |
| 13 | 2021 | 12 | |
| 14 | 2013 | 10 | |
| 15 | 2008 | 7 | |
| 16 | 2019 | 6 | |
| 17 | 2014 | 3 | |
| 18 | 2014 | 3 | |
| 19 | 2020 | 2 | |
| 20 | 2014 | 2 |
About Ashley Milton
Ashley Milton is a scholar working on Oncology, Surgery, Genetics, Epidemiology and Cell Biology, having authored 22 papers that have together received 316 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (4 papers), Microtubule and mitosis dynamics (3 papers), Microscopic Colitis (3 papers), Inflammatory Bowel Disease (3 papers), Cancer-related Molecular Pathways (2 papers), Eosinophilic Esophagitis (2 papers), Biosimilars and Bioanalytical Methods (2 papers) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Pharmacology (44 citations), Pharmaceutical Science (32 citations), Biomaterials (42 citations), Oncology (73 citations) and Gastroenterology (12 citations). Ashley Milton has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Karthik Venkatakrishnan, J.-L. Baulieu, Lydiane Pichard‐Garcia, Xiaofei Zhou, P Maurel, Jean‐Michel Fabre, Ruth Hyland, Mark Gardner, Cristina Oliva and Diane R. Mould. Their work appears in journals such as British Journal of Clinical Pharmacology, Journal of Clinical Oncology, Gastroenterology, The Journal of Clinical Pharmacology and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.